177 related articles for article (PubMed ID: 2002459)
1. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of imidazole analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Cristalli G; Eleuteri A; Franchetti P; Grifantini M; Vittori S; Lupidi G
J Med Chem; 1991 Mar; 34(3):1187-92. PubMed ID: 2002459
[TBL] [Abstract][Full Text] [Related]
2. Adenosine deaminase inhibitors. Synthesis of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S; Lupidi G; Riva F
J Med Chem; 1984 Mar; 27(3):274-8. PubMed ID: 6699873
[TBL] [Abstract][Full Text] [Related]
3. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA
J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608
[TBL] [Abstract][Full Text] [Related]
4. Modifications of flexible nonyl chain and nucleobase head group of (+)-erythro-9-(2's-hydroxy-3's-nonyl)adenine [(+)-EHNA] as adenosine deaminase inhibitors.
Kandalkar SR; Ramaiah PA; Joshi M; Wavhal A; Waman Y; Raje AA; Tambe A; Ansari S; De S; Palle VP; Mookhtiar KA; Deshpande AM; Barawkar DA
Bioorg Med Chem; 2017 Oct; 25(20):5799-5819. PubMed ID: 28951094
[TBL] [Abstract][Full Text] [Related]
5. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles.
Cristalli G; Eleuteri A; Volpini R; Vittori S; Camaioni E; Lupidi G
J Med Chem; 1994 Jan; 37(1):201-5. PubMed ID: 8289197
[TBL] [Abstract][Full Text] [Related]
6. Adenosine deaminase inhibitors. Synthesis and biological evaluation of C1' and nor-C1' derivatives of (+)-erythro-9-(2(S)-hydroxy-3(R)-nonyl)adenine.
Harriman GC; Poirot AF; Abushanab E; Midgett RM; Stoeckler JD
J Med Chem; 1992 Oct; 35(22):4180-4. PubMed ID: 1433220
[TBL] [Abstract][Full Text] [Related]
7. Adenosine deaminase inhibitors: synthesis and biological evaluation of unsaturated, aromatic, and oxo derivatives of (+)-erythro-9-(2'S-hydroxy-3'R-nonyl)adenine [(+)-EHNA].
Pragnacharyulu PV; Varkhedkar V; Curtis MA; Chang IF; Abushanab E
J Med Chem; 2000 Nov; 43(24):4694-700. PubMed ID: 11101360
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of adenosine deaminase from several sources by deaza derivatives of adenosine and EHNA.
Lupidi G; Cristalli G; Marmocchi F; Riva F; Grifantini M
J Enzyme Inhib; 1985; 1(1):67-75. PubMed ID: 3916912
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of inhibition of calf intestinal adenosine deaminase by (+)- and (-)-erythro-9-(2-hydroxy-3-nonyl)adenine.
Porter DJ; Abushanab E
Biochemistry; 1992 Sep; 31(35):8216-20. PubMed ID: 1525161
[TBL] [Abstract][Full Text] [Related]
10. Adenosine deaminase inhibitors. Synthesis and biological evaluation of putative metabolites of (+)-erythro-9-(2S-hydroxy-3R-nonyl)adenine.
Vargeese C; Sarma MS; Pragnacharyulu PV; Abushanab E; Li SY; Stoeckler JD
J Med Chem; 1994 Oct; 37(22):3844-9. PubMed ID: 7966142
[TBL] [Abstract][Full Text] [Related]
11. The protonated form of 1-N6-etheno-[erythro-9-(2-hydroxy-3-nonyl)] adenine is identified at the active site of adenosine deaminase.
Caiolfa VR; Gill D; Parola AH
FEBS Lett; 1990 Jan; 260(1):19-22. PubMed ID: 2153576
[TBL] [Abstract][Full Text] [Related]
12. Tryptophan environment in adenosine deaminase. I. Enzyme modification with N-bromosuccinimide in the presence of adenosine and EHNA analogues.
Mardanyan S; Sharoyan S; Antonyan A; Armenyan A; Cristalli G; Lupidi G
Biochim Biophys Acta; 2001 Mar; 1546(1):185-95. PubMed ID: 11257521
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of adenosine deaminase. Studies in combining high-affinity enzyme-binding structural units. erythro-1,6-Dihydro-6-(hydroxymethyl)-9-(2-hydroxy-3-nonyl)purine and erythro-9-(2-hydroxy-3-nonyl)purine.
Woo PW; Baker DC
J Med Chem; 1982 May; 25(5):603-5. PubMed ID: 7086847
[TBL] [Abstract][Full Text] [Related]
14. Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide.
Volpini R; Camaioni E; Lupidi G; Vittori S; Cristalli G
Farmaco; 1997; 52(6-7):429-33. PubMed ID: 9372594
[TBL] [Abstract][Full Text] [Related]
15. Adenosine deaminase inhibitors. Synthesis and biological evaluation of 4-amino-1-(2(S)-hydroxy-3(R)-nonyl)-1H-imidazo[4,5-c]pyridine (3-deaza-(+)-EHNA) and certain C1' derivatives.
Harriman GC; Abushanab E; Stoeckler JD
J Med Chem; 1994 Jan; 37(2):305-8. PubMed ID: 8295218
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice.
Lambe CU; Nelson DJ
Biochem Pharmacol; 1982 Feb; 31(4):535-9. PubMed ID: 7066021
[TBL] [Abstract][Full Text] [Related]
17. Inhibition studies on membrane adenosine deaminase from human placenta.
Lupidi G; Marmocchi F; Cristalli G
Biochem Mol Biol Int; 1998 Dec; 46(6):1071-80. PubMed ID: 9891839
[TBL] [Abstract][Full Text] [Related]
18. Conformational change of adenosine deaminase during ligand-exchange in a crystal.
Kinoshita T; Tada T; Nakanishi I
Biochem Biophys Res Commun; 2008 Aug; 373(1):53-7. PubMed ID: 18549808
[TBL] [Abstract][Full Text] [Related]
19. Adenosine uptake and deamination regulate tonic A2a receptor facilitation of evoked [3H]acetylcholine release from the rat motor nerve terminals.
Correia-de-Sá P; Ribeiro JA
Neuroscience; 1996 Jul; 73(1):85-92. PubMed ID: 8783232
[TBL] [Abstract][Full Text] [Related]
20. Sedative and electroencephalographic actions of erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA): relationship to inhibition of brain adenosine deaminase.
Mendelson WB; Kuruvilla A; Watlington T; Goehl K; Paul SM; Skolnick P
Psychopharmacology (Berl); 1983; 79(2-3):126-9. PubMed ID: 6405420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
